Replies to post #12226 on Plandai Biotechnology Inc (PLPL)

[tradetrak]

First the sale, then the delivery, and then... the REVENUE.

Plandai Biotechnology, Inc. Delivers on First Purchase Order of Green Tea Extract to USN
9:03 AM ET 5/21/15 | Marketwired

PlandaÃ? Biotechnology, Inc. (OTCQB: PLPL) ("PlandaÃ?" or "the Company"), producer of the highly bioavailable PhytofareÂ? Catechin Complex, today announced that it filled its first purchase order from USN Worldwide as part of the Company's exclusive 3-year agreement to supply USN with commercial amounts of the Company's flagship green tea extract.

Callum Baylis-Duffield, Vice President of Sales and Marketing for PlandaÃ?, said, "We filled and delivered on what we expect to be the first of many purchase orders in our exclusive deal with the sports nutrition brand, USN. After many years of hard work, this deal validates our impressive clinical trial results. Companies like USN not only recognize the importance of our data from clinical trials, but they also see the benefit to offering a highly bioavailable great tea extract to their customers."

Estie Mertz, Customer Relationship Manager for Azochem Laboratories, a contract manufacturer for USN, said of the delivery, "We'd like to thank PlandaÃ? for its quick and prompt delivery. We really appreciate all of their efforts to supply our stock in South Africa promptly, and we are looking forward to doing more business with PlandaÃ?."

As more contract manufacturers come online with USN in South Africa, PlandaÃ? expects to receive, fill and deliver more purchase orders. The Company also expects that USN's purchases may ultimately expand globally into other territories where USN distributes and sells its products.

USN is a global health and nutrition supplement brand that sells products in more than 50 countries and on four continents. USN was founded in South Africa 15 years ago. All of USN's products are formulated with the backing of extensive research and scientific findings, as well as clinical trials to ensure efficacy and safety.

The exclusive agreement between PlandaÃ? and USN will allow USN to control the input costs around production, while enhancing product efficacy by replacing the generic green tea extracts it now uses in its extensive lineup of innovative and market-leading products, with the clinically proven highly bioavailable PhytofareÂ? Catechin Complex.